RA Capital Management - IKENA ONCOLOGY INC ownership

IKENA ONCOLOGY INC's ticker is IKNA and the CUSIP is 45175G108. A total of 40 filers reported holding IKENA ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
RA Capital Management ownership history of IKENA ONCOLOGY INC
ValueSharesWeighting
Q4 2021$9,405,000
-0.6%
750,0000.0%0.17%
+26.7%
Q3 2021$9,465,000
-10.1%
750,0000.0%0.13%
-22.5%
Q2 2021$10,530,000
-50.3%
750,0000.0%0.17%
-47.0%
Q1 2021$21,188,000750,0000.32%
Other shareholders
IKENA ONCOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
Omega Fund Management, LLC 2,249,123$63,538,0006.01%
CHI Advisors LLC 814,756$23,017,0004.61%
Octagon Capital Advisors LP 400,000$11,300,0004.26%
BVF INC/IL 1,599,658$45,190,0001.69%
Logos Global Management LP 419,853$11,861,0001.16%
Orbimed Advisors 2,933,941$82,884,0000.78%
Artal Group S.A. 1,549,513$43,774,0000.77%
HealthCor Management, L.P. 341,212$9,639,0000.34%
RA Capital Management 750,000$21,188,0000.32%
Nantahala Capital Management 325,000$9,181,0000.27%
View complete list of IKENA ONCOLOGY INC shareholders